Strauss H C, Gilbert M, Svenson R H, Miller H C, Wallace A G
Circulation. 1976 Sep;54(3):452-9. doi: 10.1161/01.cir.54.3.452.
The electrophysiologic effects of intravenously administered propranolol (0.1 mg/kg) on three parameters of sinus node function were examined in ten symptomatic patients with sinus node dysfunction. The patients ranged in age from 26 to 79 years. Symptoms ranged from fatigue to frank syncope. Sinoatrial (SA) block and sinus pauses were observed in one patient; sinus pauses alone were observed in three patients. Five (5/10) patients had intraatrial block; three (3/10) patients had atrioventricular block; four (4/10) patients had an intraventricular conduction disturbance. At the time of electrophysiologic study, two patients had a control spontaneous sinus cycle length that exceeded 1000 msec. Following propranolol, the mean spontaneous cycle length increased by 17.4% (924 to 1085 msec, P less than 0.005) and spontaneous second degree SA block reappeared in the one patient. The maximum escape cycle ranged from 116% to 229% of the prepacing spontaneous cycle length and was considered to be prolonged in two of ten patients. Propranolol had no significant effect on the maximum escape cycle/prepacing cycle length X 100 (%). The estimated sinoatrial conduction time (SACT) was determined in seven patients and ranged in value from 120 to 238 mes. Propranolol increased the mean value of the estimated SACT from 179 to 213 msec, P less than 0.025. Propranolol may cause marked bradyarrhythmias in some patients with sinus node dysfunction, and should be used with caution in these patients.
在10例有症状的窦房结功能障碍患者中,研究了静脉注射普萘洛尔(0.1mg/kg)对窦房结功能三个参数的电生理效应。患者年龄在26至79岁之间。症状从疲劳到明显的晕厥不等。1例患者观察到窦房(SA)阻滞和窦性停搏;3例患者仅观察到窦性停搏。5例(5/10)患者有房内阻滞;3例(3/10)患者有房室阻滞;4例(4/10)患者有室内传导障碍。在进行电生理研究时,2例患者的对照自发窦性周期长度超过1000毫秒。注射普萘洛尔后,平均自发周期长度增加了17.4%(从924毫秒增至1085毫秒,P<0.005),且该例患者再次出现了自发二度SA阻滞。最大逸搏周期为起搏前自发周期长度的116%至229%,10例患者中有2例被认为延长。普萘洛尔对最大逸搏周期/起搏前周期长度×100(%)无显著影响。7例患者测定了估计的窦房传导时间(SACT),其值在120至238毫秒之间。普萘洛尔使估计的SACT平均值从179毫秒增至213毫秒,P<0.025。普萘洛尔可能会在一些窦房结功能障碍患者中引起明显的缓慢性心律失常,在这些患者中应谨慎使用。